patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: Re: Is this good or not good?
1
Nov 12, 2007 01:41AM
1
Nov 12, 2007 05:04AM
1
Nov 12, 2007 05:17AM
1
Nov 12, 2007 05:34AM

Good point 7th. It would be rather difficult to go from .03 to 6.00 on the OTC no matter what the news.

I like the fact that being on the NAZ will permit intitutional investors in - hopeully Pluristem has them lined up.

I think it's safe to say that it all come down to news.


Nov 13, 2007 06:01AM

Nov 13, 2007 06:11AM
2
Nov 14, 2007 04:45AM
1
Nov 14, 2007 06:52AM
2
Nov 14, 2007 11:08AM
Share
New Message
Please login to post a reply